242 related articles for article (PubMed ID: 33794275)
1. Generation of Budding-Like Intestinal Organoids from Human Induced Pluripotent Stem Cells.
Onozato D; Ogawa I; Kida Y; Mizuno S; Hashita T; Iwao T; Matsunaga T
J Pharm Sci; 2021 Jul; 110(7):2637-2650. PubMed ID: 33794275
[TBL] [Abstract][Full Text] [Related]
2. [Utilization of Human iPS Cells for Evaluation of Drug Disposition and Mucosal Damages in the Small Intestine].
Iwao T
Yakugaku Zasshi; 2023; 143(3):243-247. PubMed ID: 36858557
[TBL] [Abstract][Full Text] [Related]
3. Application of Human Induced Pluripotent Stem Cell-Derived Intestinal Organoids as a Model of Epithelial Damage and Fibrosis in Inflammatory Bowel Disease.
Onozato D; Akagawa T; Kida Y; Ogawa I; Hashita T; Iwao T; Matsunaga T
Biol Pharm Bull; 2020; 43(7):1088-1095. PubMed ID: 32612071
[TBL] [Abstract][Full Text] [Related]
4. Efficient Generation of Cynomolgus Monkey Induced Pluripotent Stem Cell-Derived Intestinal Organoids with Pharmacokinetic Functions.
Onozato D; Yamashita M; Fukuyama R; Akagawa T; Kida Y; Koeda A; Hashita T; Iwao T; Matsunaga T
Stem Cells Dev; 2018 Aug; 27(15):1033-1045. PubMed ID: 29742964
[TBL] [Abstract][Full Text] [Related]
5. Comparison of human biopsy-derived and human iPS cell-derived intestinal organoids established from a single individual.
Inui T; Yamashita T; Tomita J; Yokota J; Kishimoto W; Nakase H; Mizuguchi H
Drug Metab Pharmacokinet; 2023 Feb; 48():100482. PubMed ID: 36653202
[TBL] [Abstract][Full Text] [Related]
6. Generation of Intestinal Organoids Suitable for Pharmacokinetic Studies from Human Induced Pluripotent Stem Cells.
Onozato D; Yamashita M; Nakanishi A; Akagawa T; Kida Y; Ogawa I; Hashita T; Iwao T; Matsunaga T
Drug Metab Dispos; 2018 Nov; 46(11):1572-1580. PubMed ID: 29615438
[TBL] [Abstract][Full Text] [Related]
7. Generation of mesenchyme free intestinal organoids from human induced pluripotent stem cells.
Mithal A; Capilla A; Heinze D; Berical A; Villacorta-Martin C; Vedaie M; Jacob A; Abo K; Szymaniak A; Peasley M; Stuffer A; Mahoney J; Kotton DN; Hawkins F; Mostoslavsky G
Nat Commun; 2020 Jan; 11(1):215. PubMed ID: 31924806
[TBL] [Abstract][Full Text] [Related]
8. Development of a Personalized Intestinal Fibrosis Model Using Human Intestinal Organoids Derived From Induced Pluripotent Stem Cells.
Estrada HQ; Patel S; Rabizadeh S; Casero D; Targan SR; Barrett RJ
Inflamm Bowel Dis; 2022 May; 28(5):667-679. PubMed ID: 34918082
[TBL] [Abstract][Full Text] [Related]
9. Suspension culture of human induced pluripotent stem cell-derived intestinal organoids using natural polysaccharides.
Ogawa I; Onozato D; Anno S; Hayashi H; Kanaki T; Iwao T; Matsunaga T
Biomaterials; 2022 Sep; 288():121696. PubMed ID: 36038421
[TBL] [Abstract][Full Text] [Related]
10. Brief summary of the current protocols for generating intestinal organoids.
Miura S; Suzuki A
Dev Growth Differ; 2018 Aug; 60(6):387-392. PubMed ID: 30039581
[TBL] [Abstract][Full Text] [Related]
11. Development of intestinal organoids as tissue surrogates: cell composition and the epigenetic control of differentiation.
Cao L; Kuratnik A; Xu W; Gibson JD; Kolling F; Falcone ER; Ammar M; Van Heyst MD; Wright DL; Nelson CE; Giardina C
Mol Carcinog; 2015 Mar; 54(3):189-202. PubMed ID: 24115167
[TBL] [Abstract][Full Text] [Related]
12. Generation of Mouse and Human Organoid-Forming Intestinal Progenitor Cells by Direct Lineage Reprogramming.
Miura S; Suzuki A
Cell Stem Cell; 2017 Oct; 21(4):456-471.e5. PubMed ID: 28943029
[TBL] [Abstract][Full Text] [Related]
13. From crypts to enteroids: establishment and characterization of avian intestinal organoids.
Zhao D; Farnell MB; Kogut MH; Genovese KJ; Chapkin RS; Davidson LA; Berghman LR; Farnell YZ
Poult Sci; 2022 Mar; 101(3):101642. PubMed ID: 35016046
[TBL] [Abstract][Full Text] [Related]
14. Method for Two-Dimensional Epithelial Monolayer Formation Derived from Mouse Three-Dimensional Small Intestinal Organoids.
Takase Y; Takahashi T
Methods Mol Biol; 2024; 2749():73-84. PubMed ID: 38133775
[TBL] [Abstract][Full Text] [Related]
15.
Jung KB; Lee H; Son YS; Lee JH; Cho HS; Lee MO; Oh JH; Lee J; Kim S; Jung CR; Kim J; Son MY
FASEB J; 2018 Jan; 32(1):111-122. PubMed ID: 28855280
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Barrier Functions in Human iPSC-Derived Intestinal Epithelium.
Yamada S; Kanda Y
Methods Mol Biol; 2021; 2367():27-35. PubMed ID: 33661485
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 expression, induction and activity in human induced pluripotent stem cell-derived intestinal organoids and comparison with primary human intestinal epithelial cells and Caco-2 cells.
Janssen AWF; Duivenvoorde LPM; Rijkers D; Nijssen R; Peijnenburg AACM; van der Zande M; Louisse J
Arch Toxicol; 2021 Mar; 95(3):907-922. PubMed ID: 33263786
[TBL] [Abstract][Full Text] [Related]
18. Cyclic AMP Signaling Promotes the Differentiation of Human Induced Pluripotent Stem Cells into Intestinal Epithelial Cells.
Kabeya T; Qiu S; Hibino M; Nagasaki M; Kodama N; Iwao T; Matsunaga T
Drug Metab Dispos; 2018 Oct; 46(10):1411-1419. PubMed ID: 30068521
[TBL] [Abstract][Full Text] [Related]
19. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.
Mun SJ; Ryu JS; Lee MO; Son YS; Oh SJ; Cho HS; Son MY; Kim DS; Kim SJ; Yoo HJ; Lee HJ; Kim J; Jung CR; Chung KS; Son MJ
J Hepatol; 2019 Nov; 71(5):970-985. PubMed ID: 31299272
[TBL] [Abstract][Full Text] [Related]
20. Patient-derived organoids for therapy personalization in inflammatory bowel diseases.
Lucafò M; Muzzo A; Marcuzzi M; Giorio L; Decorti G; Stocco G
World J Gastroenterol; 2022 Jun; 28(24):2636-2653. PubMed ID: 35979165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
